Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-18-055379

Director acquired 18,716 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Kazam Joshua A · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-15 Conversion : show line 1 in the form +18,716 1,390,651 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-10-15 Conversion : show line 2 in the form Series A Convertible Preferred Stock −3,565 0 D
Loading xslF345X03/doc4.xml…